TAG: "Global health"

Why dengue fever prevention efforts often fail


Twelve-year study provides insights.

Studies on dengue fever infections took UC Davis researcher Robert Reiner (foreground) to Iquitos, Peru.

Newly published research involving a 12-year study of dengue infections in Iquitos, Peru, helps explain why interventions to prevent the mosquito-borne disease are frequently unsuccessful.

The research, headed by professor Thomas Scott of the UC Davis Department of Entomology and Nematology, is published today (May 19) in the Proceedings of the National Academy of Sciences.

“Defining variation in the risk of dengue transmission has been a roadblock to understanding disease dynamics and designing more realistic and effective disease prevention programs,” said Scott, a noted dengue researcher and a senior author of the paper, “Time-Varying, Serotype-Specific Force of Infection of Dengue Virus.”

“This study is an important step toward overcoming that obstacle,” Scott said. “We hope our results will help reduce the burden of this increasingly devastating disease.”

Dengue, a mosquito-borne virus infecting nearly 400 million people a year, is difficult to model not only because the majority of all infections are hidden, but also because there are four distinct serotypes, or versions, of dengue, each having unique characteristics, said lead author Robert Reiner, a Research and Policy for Infectious Disease Dynamics (RAPIDD) postdoctoral fellow in Scott’s Mosquito Research Laboratory.

“Typically, most infections go unnoticed and as such, measuring and modeling transmission intensity is problematic,” Reiner said.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

 

CATEGORY: NewsComments Off

Harvey Fineberg named UCSF Presidential Chair


Departing Institute of Medicine chief will focus on global health during yearlong appointment.

Harvey Fineberg

Harvey V. Fineberg, M.D., Ph.D., M.P.P., the president of the Institute of Medicine (IOM), will come to UC San Francisco for a yearlong appointment as a Presidential Chair beginning in September.

Fineberg is a public health expert with a particular interest in health policy and medical decision making. He has been head of the IOM, which is the health arm of the National Academy of Sciences, for two full terms, and will step down at the end of June. Before that, Fineberg spent many years at Harvard University; first as a college and medical student, and later as a faculty member, dean of the School of Public Health and provost of the University.

At UCSF, Fineberg will write and lecture about global health policy and analysis. He will be the keynote speaker at the UCSF Science of Global Health symposium on Oct. 2, which coincides with GHS’s 10-year anniversary and the opening of Mission Hall, the new building at UCSF Mission Bay where global health, clinical and other faculty will have offices.

“UCSF is an extraordinary place, and I am very pleased to come and join its global health faculty,” Fineberg said. “It is one of the nation’s premier biomedical centers, and it has become a first-class center for global health as well.”

Fineberg was invited to UCSF by Jaime Sepulveda, executive director of UCSF Global Health Sciences (GHS), as well as Sam Hawgood, M.B.B.S., dean of the School of Medicine and interim chancellor, and David Vlahov, R.N., Ph.D., dean of the School of Nursing. Sepulveda and Fineberg have known each other since the 1980s, when Sepulveda was a graduate student at the Harvard School of Public Health. They later edited a book together about HIV prevention.

“Harvey is one of the most respected and influential leaders in academic medicine, and we at UCSF are extremely fortunate to have him as a visiting professor,” Sepulveda said. “I owe him a lot. He has been my mentor for decades, and he’s also a mentor to many others.”

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Blum Center conference examines health inequities, solutions in Latin America


Despite improvements, childhood malnutrition, anemia, vaccine delivery problems persist.

Dr. Michael Rodriguez directs the UCLA Blum Center on Poverty and Health in Latin America.

Health has improved for Latin Americans in recent decades but Ferdinando Regalia, chief of the Inter-American Development Bank’s Social Protection and Health Division, reminded attendees at the second annual UCLA Blum Center Conference why there’s still more work to be done.

He spoke about an indigenous 16-year-old woman in rural Panama who just last year gave birth to a stillborn child, an outcome that could have been prevented if she had received treatment at a health clinic.

Regalia said it was “one of the thousands of deaths that happen every day in silence without witnesses, but with the same pain and affliction as (if we’re talking) about our daughters, wives and friends.”

“Let’s not forget about their babies,” he told the audience gathered to hear opening remarks at the conference organized by the UCLA Blum Center for Health and Poverty in Latin America.

The conference drew approximately 150 attendees, including health ministry and other government and community officials from 10 Latin American nations, on Tuesday and Wednesday to hear about health issues in the region as well as solutions.

Cindy Fan, UCLA vice provost for international studies, also spoke during the conference’s opening remarks, noting that the university has at least 150 faculty members in 28 academic fields that work on Latin American research. Units such as the Latin American Institute and the Blum Center are also focused on the region.

“The (Blum) Center seeks to anticipate policy changes and devise strategies to improve health and reduce poverty and address and combat inequities among disadvantaged populations and these are really important missions that a campus like UCLA is embracing,” she added.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCSF joins research partnership to eliminate malaria in Namibia


University’s work already has contributed to 98 percent drop in malaria cases in Namibia.

As we mark World Malaria Day this year, UC San Francisco’s Global Health Group is celebrating the success of Namibia, where malaria case have dropped 98 percent over the past decade.

In 2003, Namibia saw 450,000 cases of malaria; in 2013, that number fell to 2,500. The country is now on track to becoming malaria-free by 2020.

The deadly disease, caused by parasites that are transmitted from person to person by mosquitoes, is now found mostly in the northern regions of Namibia.

The National Vector-borne Disease Control Program (NVDCP) at the Namibia Ministry of Health and Social Services effectively controls the spread of malaria with interventions such as spraying dwellings with insecticides, distributing mosquito nets treated with insecticides, using malaria tests that can give accurate results within 15 minutes, and distributing medicines that kill the parasite.

To further this success, the UCSF Global Health Group’s Malaria Elimination Initiative is teaming up with the Multidisciplinary Research Centre at the University of Namibia, the Novartis Foundation for Sustainable Development, the London School of Hygiene and Tropical Medicine, the Clinton Health Access Initiative, and others to research new strategies and interventions that the NVDCP can use to get rid of the remaining pockets of transmission and eliminate malaria by 2020. Members of this research partnership will be working together to strengthen the national malaria surveillance system, learn more about how to eliminate the remaining reservoirs of infection in the Zambezi region and understand the risk factors that are associated with malaria transmission.

Worldwide, an estimated 3.3 million lives have been saved since 2000 through stepped up malaria control and elimination efforts, according to the World Health Organization. Mortality rates have been cut almost in half.

UCSF’s Global Health Group received a $15 million grant from the Bill & Melinda Gates Foundation in December to help nearly three dozen countries eliminate malaria within their borders.

In 2012, an estimated 207 million people got sick from malaria, and 627,000 of them died, mostly children under five in sub-Saharan Africa. In 2013, 97 countries had ongoing malaria transmission.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Grad students to present research on STDs, parasites in Latin America


UCLA Blum Center conference to feature latest research on health, poverty in Latin America.

UCLA graduate student Claire Bristow conducted research at a Peruvian university.

In Peru, HIV and syphilis are more widespread among transgender women and men who have sex with men, and so ensuring that these groups get tested and treated is crucial.

A research project supported by UCLA’s Blum Center for Poverty and Health in Latin America is contributing to efforts in Peru to make this happen.

Claire Bristow, a UCLA Ph.D. student in public health who conducted research in Peru, and Rebecca Foelber, a master’s student in public health who worked in Brazil on another project, will present their research on behalf of the center at its Second Annual Spring Conference May 6-7 at UCLA’s De Neve Auditorium. Bristow and Foelber were selected for the Blum Center’s inaugural Summer Scholars Program.

Conference participants, who include UCLA students, faculty and staff as well as policy and health professionals from 10 Latin American countries, will discuss the latest research on health and poverty in Latin America. The conference will also highlight solutions and projects such as Bristow’s.

“The Summer Scholars Program was developed for students to examine how poverty, government practices and policies, and other factors impact poor health in Latin America,” said Dr. Michael Rodriguez, Blum Center director. “More importantly, the scholars’ research can lead to better health practices and solutions in a region that is so desperately in need of them.”

Bristow spent last summer in Lima, Peru, where she developed a study that asked people in these high-risk groups what type of HIV and syphilis testing they would prefer.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Experts ponder how to achieve global access to quality health care


UCLA Center for World Health celebrates launch with panel discussion.

Thomas Coates, UCLA

A young man at a drug rehabilitation center in Anantapur, India, lies chained to his bed, ostensibly to prevent the spread of HIV. With ankles blackened by gangrene, another afflicted with the virus accepts clean needles from a health worker on the streets of Puerto Rico. A third patient endures a 14-hour ambulance trip from his home in Laredo, Mexico, so he can die at an AIDS hospice in Tijuana.

In a darkened auditorium at Ronald Reagan UCLA Medical Center, an audience watched somberly as slide after slide, provided by science writer Jon Cohen, illustrated the human toll of HIV and the varied, sometimes inhumane responses to it — in South Africa, Haiti, Russia, the Ukraine and the United States.

But there was also a strong sense of optimism at this event that, with the right investments in health policy, people in rich and poor countries around the world can enjoy long lives and equal access to quality health care by the next generation. That’s the message that approximately 175 attendees packed into Tamkin Auditorium heard on April 15 at a panel discussion held to celebrate the inauguration of the UCLA Center for World Health.

Experts in global health came together to discuss the goal of achieving equal lifespans and global access to quality health care by 2035, a concept called “grand convergence,” coined by the Lancet Commission on Investing in Health. Moderator Thomas J. Coates, director of the new UCLA Center for World Health, invited them to define “what we need to do to take the science and really make a difference.”

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UC Global Health Day to be April 26


UC Davis hosting annual event.

UC Davis and the University of California Global Health Institute will host global health leaders from California and beyond on Saturday, April 26, during the fourth annual UC Global Health Day.

Topics ranging from global health diplomacy, maternal and child health, animal health, emerging infectious diseases, economics, migrant health, and more will be presented by faculty and students from across the 10-campus University of California system.

Keynote speakers will include UC President Janet Napolitano, former U.S. secretary of Homeland Security and governor of Arizona.

“When we talk about global health, we are speaking about the health of people not only in developing countries, but also throughout the United States,” Napolitano said. “With five medical centers, world-class health research initiatives and top-ranked educational programs, the University of California is making an enormous impact on the health of populations across the world, including people in need right here in California.”

The annual event, being hosted by UC Davis, rotates among the UC campuses. Past events have taken place at Irvine, Berkeley and Riverside.

“Global health is an increasingly popular field of study at UC Davis and we are thrilled to be hosting UC Global Health Day this year,” said UC Davis Chancellor Linda P.B. Katehi, who will give welcoming remarks at the event. “Because of our particular strengths in agriculture, medicine, veterinary medicine and engineering, UC Davis is uniquely positioned to address the biggest challenges of health worldwide.”

Registration for UC Global Health Day is open until April 22: $50 general admission; $25 for students. For more information, visit the UCGHI website at: www.ucghi.universityofcalifornia.edu/index.aspx.

Two UC Davis professors — Andrew Hargadon, the Charles J. Soderquist chair in entrepreneurship at the Graduate School of Management, and Jonna Mazet, director of the One Health Institute in the School of Veterinary Medicine —  will jointly present a talk on “How Breakthroughs Happen.” Jonathan Samet, director of the Institute of Global Health at the University of Southern California, will speak about “Moving beyond Global Tobacco Control to Global Noncommunicable Disease Control.”

Students and faculty from every UC campus will be in attendance at the all-day event, which will also feature 60 poster presentations and 16 breakout sessions, covering a broad range of global health topics, including:

  • Migration and Human Trafficking in the Pacific Rim;
  • Innovation and Infrastructure for Slum Health: Advancing Technology to Work in Low-Resource Settings;
  • 21st Century Global Health Diplomacy;
  • Working Globally at the Human-Animal Interface to Improve Health for All; and
  • Measuring Women’s Empowerment through Participatory Action.

See a video about the 2013 UC Global Health Day at http://youtu.be/3s5KbWfPU9E.

The UC Global Health Institute was established in November 2009 in response to the growing demand from students and faculty interested in global health research and education. The UCGHI convenes people from across the UC system to collaborate on research projects, and provides education and training opportunities through workshops, courses, lectures and other events. The UCGHI is composed of three multi-campus Centers of Expertise — Migration & Health; One Health; and Women’s Health & Empowerment. These centers lead education and training programs to produce leaders and practitioners of global health, conduct innovative research, and develop international partnerships to improve the health of vulnerable people and communities in California and worldwide.

Patricia Conrad, a professor in the UC Davis School of Veterinary Medicine, is co-director of the One Health Center of Expertise and led the planning for 2014 UC Global Health Day.

“It’s exciting to see the enthusiasm for global health at UC Davis and across the UC campuses,” Conrad said. “The diversity of presentations at this year’s event, and the cross-section of disciplines of the faculty and student participants, is quite remarkable.”

The UC Global Health Institute is jointly led by director Haile Debas, former chancellor and dean of the School of Medicine at UC San Francisco, and Thomas Coates, the Michael and Sue Steinberg professor of global AIDS research at the UCLA David Geffen School of Medicine and director of the UCLA Center for World Health. The institute has received $4 million in funding from the Chan Soon-Shiong Family Foundation and $4 million from the Bill & Melinda Gates Foundation, in addition to funds from the UC Office of the President.

Media contacts:

CATEGORY: NewsComments Off

Community-based HIV prevention can boost testing


Prevention efforts also can help reduce new infections, study shows.

Thomas Coates, UCLA

Communities in Africa and Thailand that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study in the peer-reviewed journal The Lancet Global Health.

The U.S. National Institute of Mental Health’s Project Accept — a trial conducted by the HIV Prevention Trials Network to test a combination of social, behavioral and structural HIV-prevention interventions — demonstrated that a series of community efforts boosted the number of people tested for HIV and resulted in a 14 percent reduction in new HIV infections, compared with control communities.

Much of the research was conducted in sub-Saharan Africa, which has particularly high rates of HIV. The researchers were interested not just in how the clinical trial participants’ behavior changed, but also in how these efforts affected the community as a whole, said Thomas Coates, Project Accept’s overall principal investigator and director of UCLA’s Center for World Health.

“The study clearly demonstrates that high rates of testing can be achieved by going into communities and that this strategy can result in increased HIV detection, which makes referral to care possible,” said Coates, who also is an associate director of the UCLA AIDS Institute. “This has major public health benefit implications — not only suggesting how to link infected individuals to care, but also encouraging testing in entire communities and therefore also reducing further HIV transmission.”

These findings were previously presented at the 2013 Conference on Retroviruses and Opportunistic Infections in Atlanta.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCLA launches joint venture with Chinese firm to open lab in Shanghai


Clinical laboratory will provide more accurate diagnoses of cancer and other diseases.

Scott Binder, UCLA

The University of California and UCLA Department of Pathology have signed an agreement with Centre Testing International Corp., a Chinese firm, to create a company that will operate a clinical laboratory in Shanghai. The new lab will support clinical trials and enhance medical care for Chinese patients with cancer and other diseases.

The new company, CTI-Pathology/UCLA Health, is jointly owned by CTI and the University of California. The 25,000-square-foot facility — the first of its kind in China — will offer genetic and molecular diagnostics and other sophisticated tests that exceed the scope of the average lab in China, and UCLA pathologists will train Chinese lab specialists to accurately interpret the tests. The lab is expected to open in September.

The partnership is the first between a Chinese company and a U.S. academic medical center to create a specialized laboratory in China. The agreement was signed today at Ronald Reagan UCLA Medical Center in a ceremony that was videocast to China.

“This joint venture is founded on UCLA’s desire to build strong global relationships that, through education, research and service, improve the health of people and communities throughout the world,” said Dr. Tom Rosenthal, chief medical officer for UCLA Health System and co-director of UCLA’s Center for World Health. “UCLA has a genuine interest in elevating the level of medicine around the world. This is one way we can really make a difference in the quality of the Chinese people’s health care and lives.”

UCLA will oversee management of the laboratory to ensure that its operations meet international standards for quality, and CTI will provide capital funding and marketing expertise. The University of California Regents approved the joint venture on Jan. 22.

“We are extremely pleased that the UCLA Health System, UCLA Department of Pathology and the UC Regents agreed to partner with CTI to establish and manage our joint venture laboratory in Shanghai,” said Sangem Hsu, president of CTI. “Our collaboration will offer the people of China oncology, pathology and laboratory medicine services they can trust. Many of these services are not largely available in China and are needed by physicians and health care providers to accurately diagnose and treat their patients.”

The Shanghai laboratory will be electronically and digitally linked with UCLA — enabling physicians and patients to consult with UCLA pathologists — and with hospitals, clinics and other laboratories throughout China.

“CTI will be an outstanding partner in our effort to significantly improve patient care in China,” said Dr. Scott Binder, senior vice chair of pathology and laboratory medicine at the Geffen School of Medicine, and director of pathology laboratory services for UCLA Health System, which performs more than 7 million tests and diagnose more than 90,000 tissue specimens a year.

Jianyu Rao, UCLA

Binder conceived the idea for a UCLA lab in China and made the first of several visits there in 2005. Dr. Jianyu Rao, a UCLA colleague who speaks Mandarin, helped move the plan forward.

“In the past, Chinese medicine focused more on treatment than diagnosis,” said Rao, a professor of pathology and laboratory medicine at the Geffen School of Medicine and director of cytopathology at UCLA Health System. “Due to the rise of a more-informed middle class, the Chinese people are recognizing the importance of accurate diagnoses for their conditions.”

The partnership also has led to teaching exchanges between UCLA and China. UCLA has already hosted Chinese pathologists and technologists for training on specialized diagnostics for skin, blood and brain tissue and other areas. In turn, UCLA pathologists will travel to China to learn about diseases that are common there but rare in the U.S.

“Because pathology has a history of being undervalued in China, the country has a shortage of pathologists trained to diagnose and interpret complex test results in specialized fields of medicine,” Binder said. “Our partnership gives CTI and UCLA the opportunity to save lives by changing that.”

View original article

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Saving diabetics from blindness in Libya


UC Berkeley grad student, professor, alum join forces in international public service project.

UC Berkeley optometry student Fatima Elkabti and professor Jorge Cuadros discuss a magnified digital image of a healthy retina.

A UC Berkeley graduate student in optometry, one of her professors and a Berkeley alumnus have joined forces to build a long-distance diagnostic project that has the potential to keep a large number of people in crisis-torn Libya from going blind.

The public service project involves training Libyan doctors to take detailed digital photographs inside patients’ eyes, of their retinas, as part of routine health care and put the images online for remote diagnosis of damage caused by diabetes before it’s too late. Too often, diabetes-related retinopathy isn’t caught until it causes symptoms, when treatment can no longer save vision.

The first 11 Libyan doctors underwent training for three days in February in Istanbul, in a seminar organized by the Avicenna Group and taught by Berkeley optometry professor Jorge Cuadros. Turkey was chosen as the training site for security reasons and because it is easily accessible from Libya.

If all goes according to plan, many more doctors will be trained over the next year, both in Libya and out — all because of a project that developed rapidly from a seed planted in a Diabetic Health Clinic class in Berkeley’s School of Optometry.

In the class, Cuadros taught students how to analyze photos of diabetic retinopathy as part of EyePACS, the California-based online initiative he co-founded to train people working in diabetes care to screen patients’ vision for remote diagnosis by certified eye doctors.

In his class was third-year optometry student Fatima Elkabti, who knows firsthand the toll that diabetes is taking in Libya, where the disease is rampant but greatly underdiagnosed. Elkabti’s father, a Libyan, has diabetes, as do about half of her many aunts and uncles.

“I walked out of the class and asked Dr. Cuadros, ‘Can we do this in Libya?’ “ Elkabti relates. Do some research, the professor told her.

Elkabti got to work and within an hour found Ethan Chorin, who earned his Ph.D. at Berkeley in 2000, served in the U.S. diplomatic corps in Libya from 2004 to 2006 and has published a book about the recent Libyan revolution. He founded the not-for-profit Avicenna Group in 2011 with a Libyan-American colleague to catalyze health-related partnerships between Libyan organizations and U.S. universities. Traveling back and forth between Benghazi and Berkeley, he looked for ways to involve Berkeley in Libya’s reconstruction efforts.

“I shot Ethan an email, and within hours we were talking about how to make this happen,” Elkabti says. The Berkeley-Libya retinopathy project was off and running.

Diabetes-related retinopathy is one of the leading causes of blindness in Libya — as well as in the United States and in much of the world. EyePACS has brought retinal screenings to poor and medically underserved areas from California’s Central Valley to Peru, and the Libyan retinopathy project extends the concept to politically unstable and dangerous regions.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Indian company licenses Berkeley Lab invention for arsenic-free water


Technology could help save millions of lives in India and Bangladesh.

When Lawrence Berkeley National Laboratory (Berkeley Lab) scientist Ashok Gadgil set out to solve an insidious public health problem afflicting South Asia, arsenic contamination of groundwater, he knew the hard part would not just be inventing the technology but also ensuring a way to sustain its long-term use on a large scale.

“A lot of technologies to remove arsenic on the community- and household- scale have been donated. But if you go to these villages it’s like a technology graveyard,” said Gadgil, who heads the Lab’s Environmental Energy Technologies Division and is also a professor of civil and environmental engineering at UC Berkeley. “One study found that more than 90 percent failed within six months, and then were abandoned to rust in the field.”

So Gadgil and his lab came up with ECAR, Electrochemical Arsenic Remediation, which binds arsenic using iron dissolved in water. Their innovation was twofold. They created a technology that is exceptionally effective, inexpensive and easy to maintain. And just as importantly, from the start they conceptualized a business model for implementing the technology in a way that creates incentives for its longevity.  Now Indian company Luminous Water Technologies has licensed ECAR and plans to bring it to arsenic-affected villages throughout India and Bangladesh.

“Technology alone is not enough. It has to fit within a sustainable system based on partnerships with local entities,” said Susan Amrose, who has worked on ECAR since 2008 as the lead project scientist in Gadgil’s lab. “Other technologies have failed because there is no system of incentives or money or knowledge to keep them running. The key difference with ECAR is that it was designed to fit within a local system aimed at achieving successful social placement — so a flow of funds pays for ongoing operation, maintenance and social marketing, without turning it into privatized water.”

Arsenic-contaminated groundwater can be found all over the world, including in the United States, but the problem is particularly acute in South Asia, where tens of millions of people in India and Bangladesh get their drinking water from tube wells highly contaminated with arsenic, almost all of it occurring naturally. Arsenic poisoning, or arsenicosis, can cause painful lesions, diabetes, cancer and blood vessel diseases that often lead to gangrene, amputation and premature death.

Amrose has seen the devastation first-hand in her travels to affected villages. “Over time you’ll see people get worse and worse,” she said. “There was one man who in 2009 had lost his right pinkie finger by amputation due to arsenic. In 2011 he lost his right hand, and in 2013 lost his entire arm. Earlier this year he committed suicide. In some areas, you’ll see a lot of people with black spots on their palms, an external sign of arsenicosis. And a lot of things you won’t see. People will be linked with arsenic and ostracized, or young people unable to marry because their family lives in an area that has arsenic.”

One of the aims of Gadgil’s lab is to reduce the time lag between invention and commercialization from 18 years, the current norm, to 10 years. “We’re actually quite on target with ECAR,” Amrose said.

They started work on the concept in 2005. They’re now preparing a 10,000 liter-per-day trial over 15 months. “As we get to larger-scale field trials we’re intent on conducting them with our field partners,” Amrose said. “By working on a common goal, we get to effectively transfer the technology know-how, while they guide us towards what needs to be done to effectively scale up.”

Luminous Water Technologies was founded by an Indian serial entrepreneur, Rakesh Malhotra, with the aim of providing clean drinking water and commercializing new technologies in the drinking water market. Luminous’ current focus is on reverse osmosis systems, and they were looking to diversify in other water technologies when they identified ECAR for licensing.

“Arsenic poisoning is an endemic problem in India and Bangladesh and is seen as a silent killer,” said Luminous Managing Director RS Rajan. “It is Dr. Gadgil’s conviction and perseverance which has been a key motivating factor in Luminous opting for this technology. Luminous Water, with its reach across India and longstanding business record, will work towards commercializing this technology along with Berkeley Lab and create a sustainable module to provide solutions to impacted communities.”

ECAR works by using electricity to quickly dissolve iron in water. This forms a type of rust that readily binds to arsenic; the rust can then be separated from the water through filtration or settling. For the remaining waste Gadgil’s lab is now working on partnerships with cement and concrete companies to do research on embedding the sludge in concrete.

“We find in early tests that it’s very well stabilized, and the arsenic is not getting back into the environment,” Amrose said. “We expect and hope this form of sludge management will be viable and pass environmental approvals for market scale-up. Until then Luminous will dispose of the waste according to prevailing pollution control guidelines.”

ECAR is envisaged to operate as a village-owned micro utility in the villages where it is installed. Luminous would operate and maintain the utility and sell the water, with concurrent support for social marketing and education.

Last year ECAR was awarded a UC Proof of Concept Program Commercialization Gap Grant to see if it could be used to remediate arsenic-contaminated groundwater in California. Rural communities in California are often too poor to afford commonly available arsenic remediation techniques, and most techniques are only cost effective on larger scales, such as the city water supply system. As a result, many California residents drink water with dangerous levels of arsenic every day. The burden falls disproportionately on minorities and residents of lower socioeconomic status, particularly migrant farming communities and Native American communities.

ECAR has yet to be proven in California groundwater, which is known to contain a different composition of interfering ions from that in South Asia. This grant funds a proof-of-concept demonstration of ECAR in California to reduce entry risk for potential licensees.

The ECAR effort was initiated at Berkeley Lab with internal seed funds (from Laboratory Directed Research and Development funding) in 2005. It is being further developed in part with funding from the Development Impact Lab at UC Berkeley. ECAR technology is available for licensing in the United States. For more on Gadgil’s arsenic removal research visit arsenic.lbl.gov.

View original article

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UC Global Health Day registration opens


Event will be April 26 at UC Davis.

The 2014 UC Global Health Day is a showcase of the research, training and outreach in global health being undertaken across the University of California. This event is a unique opportunity to hear from University of California faculty, students and staff about the diversity of global health work they are doing around the world. The day will feature plenary sessions, posters and several concurrent breakout sessions covering a broad range of global health topics. Learn more about this event.

Online registration is now open. Please click here to register. Space is limited so register today.

The registration fee is $50 for general admission, $25 for students (Registration is non-refundable; one ticket per person, per transaction) Note: If you are a poster presenter or breakout session presenter, you will receive complimentary registration, so please do NOT register online.

Keynote speakers for the 2014 UC Global Health Day include:

  • Janet Napolitano, president, University of California
  • Jonathan M. Samet, director, USC Institute for Global Health; Distinguished Professor and Flora L. Thornton Chair, Department of Preventive Medicine, University of Southern California Keck School of Medicine
  • Andrew Hargadon, Charles J. Soderquist Chair in Entrepreneurship; professor of technology management; founding director, Center for Entrepreneurship, UC Davis Graduate School of Management
  • Jonna Mazet, executive director, One Health Institute; professor of epidemiology and disease ecology, UC Davis School of Veterinary Medicine

The deadline for the UC Global Health Day Video Challenge is soon approaching (March 31). This video challenge is your chance to share your passion for global health and showcase your work in the field. For details, click here.

Visit the UCGHI website for more information.

Related link:
Global health videos on UCTV

CATEGORY: NewsComments Off